The World Health Organization (WHO) has confirmed the emergence of a new recombinant strain of the monkeypox virus (MPXV), identified in both the United Kingdom and India. This strain combines genomic elements from clades Ib and IIb. Both cases involved individuals with recent travel histories, though neither experienced severe illness. Importantly, no secondary cases have been detected following extensive contact tracing efforts.
The announcement comes as WHO releases a comprehensive update on the cases and the national responses involved. Recombination, a natural process where related viruses infect the same host and exchange genetic material, is responsible for this new variant. According to WHO, genomic analysis indicates that the two patients “fell ill several weeks apart with the same recombinant strain,” suggesting the possibility of additional, undetected cases.
Details of the Detected Cases
The case in the United Kingdom was identified in December 2025, involving a traveler returning from the Asia Pacific region. Initial laboratory tests identified the virus as clade Ib, but further genome sequencing revealed genetic regions from both clade Ib and clade IIb. Repeat sequencing confirmed these findings, indicating that the virus “can replicate and presents potential for onward transmission.”
Meanwhile, in India, a patient who developed symptoms in September 2025 was initially classified as infected with clade II MPXV. Subsequent updates to global genomic databases led to the reclassification of the virus as the same recombinant strain found in the UK. This Indian case represents the earliest known detection of this strain.
“Due to the small number of cases found to date, conclusions about transmissibility or clinical characterization of mpox due to recombinant strains would be premature, and it remains essential to maintain vigilance regarding this development,” WHO stated.
Clinical presentations in both cases were consistent with known mpox infections, underscoring the need for continued vigilance.
Global Risk Assessment and Recommendations
Despite the emergence of this new strain, WHO’s overall risk assessment remains unchanged. The risk is considered moderate for men who have sex with men with new and/or multiple partners and for sex workers or others with multiple casual sexual partners. For the general population without specific risk factors, the risk is assessed as low.
WHO has cautioned that clade differentiation PCR tests alone “may not reliably identify recombinant MPXV strains,” emphasizing the necessity of genomic sequencing for accurate detection. The organization has urged all countries to remain alert to the potential for MPXV genetic recombination, advocating for continued epidemiological surveillance, sequencing, vaccination of at-risk groups, and robust infection prevention and control measures.
“All countries should remain alert to the possibility of MPXV genetic recombination,” WHO advised, while noting that no travel or trade restrictions are warranted based on current information.
Implications and Forward-Looking Analysis
The discovery of a recombinant mpox strain in two geographically distinct regions highlights the interconnected nature of global health. As international travel resumes post-pandemic, the potential for rapid virus spread increases, necessitating a coordinated global response. Experts suggest that the current situation serves as a reminder of the importance of global health vigilance and preparedness.
Historically, recombinant strains have posed challenges in managing viral outbreaks, as seen with other viruses like influenza. The ability of viruses to exchange genetic material can lead to new variants that may evade existing vaccines or treatments, underscoring the need for ongoing research and adaptation in public health strategies.
Looking ahead, the focus will likely remain on enhancing genomic surveillance and ensuring that health systems worldwide are equipped to detect and respond to emerging viral threats swiftly. As the situation develops, WHO and national health authorities will continue to monitor the strain’s behavior and provide updates to the global community.
The emergence of this new mpox strain underscores the ongoing need for vigilance and international cooperation in the face of evolving viral threats. While the immediate risk remains low for the general population, the situation serves as a critical reminder of the dynamic nature of infectious diseases and the importance of preparedness.
